EQUICENTA
Live / Registered — Registered (as of 01 Sept 2026)
What this means for you
Registered since 01 Sept 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 01 Sept 2032: the §8 declaration of use).
Record
- Serial number
- 99420105
- Registration number
- 8427726
- Mark type
- Word mark
- Filed
- 30 Sept 2025
- Published for opposition
- 03 Mar 2026
- Registered
- 01 Sept 2026
- Next maintenance filing
- §8 declaration of use, due by 01 Sept 2032 (grace period to 01 Mar 2033)
- Attorney of record
- Lynn E. Rzonca
Goods and services
- Class 005 — Pharmaceuticals: Veterinary preparations for equine joints, tendons and ligaments, namely, cryopreserved microparticulate equine umbilical cord tissue allografts
Owner
- Equine Performance Labs, Austin, TX, US
- Equine Performance Labs, Austin, TX, US
- Equine Performance Labs, Austin, TX, US
Prosecution history
- 01 Sept 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 01 Sept 2026 — REGISTERED-PRINCIPAL REGISTER
- 13 Aug 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Aug 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 21 Jul 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 11 May 2026 — USE AMENDMENT FILED
- 21 Jul 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 May 2026 — TEAS STATEMENT OF USE RECEIVED
- 28 Apr 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Mar 2026 — PUBLISHED FOR OPPOSITION
- 25 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Feb 2026 — ASSIGNED TO EXAMINER
- 30 Sept 2025 — APPLICATION FILING RECEIPT MAILED